Advertisement
News
Advertisement

Insulet signs insulin device distribution deal with GSK

Wed, 03/02/2011 - 9:38am
Mass High Tech: The Journal of New England Technology

Bedford-based medical device maker Insulet Corp. has signed an exclusive distribution agreement with GlaxoSmithKline Inc. in Canada. The deal relates to Insulet’s OmniPod Insulin Management System, a tubing-free insulin pump designed for continuous insulin delivery.

The agreement calls for GSK to gain exclusive marketing, promotion, advertising, distribution and sales rights for the OmniPod in Canada.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading